Vineet Laboratories per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹2.51₹1.00−₹21.90₹1.11₹1.36
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹2.51₹1.00−₹21.90₹1.11₹1.36
₹23.74₹23.74₹15.89₹37.67₹36.54
₹32.46₹30.92₹81.35₹163.35₹230.28
—−₹6.37₹12.46−₹12.40−₹10.43
−₹7.00−₹7.00₹11.33−₹12.65−₹18.71
—₹0.00₹0.00₹0.00₹1.00
1.91.90.90.90.9
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

VINEETLAB₹36.06

Vineet Laboratories Limited

· Pharma & Health
₹ CrorePeersBIOFILCHEMMANGALAMLASAKREBSBIOALPABALPHARMAORTINGLOBENATCAPSUQMcap ₹69.3 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS1.361.11-21.901.002.51
Diluted EPS1.361.11-21.901.002.51
Book Value per Share36.5437.6715.8923.7423.74
Revenue per Share230.28163.3581.3530.9232.46
Cash Flow per Share-10.43-12.4012.46-6.37—
Free Cash Flow per Share-18.71-12.6511.33-7.00-7.00
Dividends per Share1.000.000.000.00—
Shares Outstanding (cr)0.90.90.91.91.9
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.